Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMEM208 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | HIBCH | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | TIPRL | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | KRTCAP2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | FAM72A | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
mRNA | ZDHHC17 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | NOL10 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | GAGE12B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | TMED3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |